language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
TPVGTPVG

$5.96

+0.01
arrow_drop_up0.17%
Market closed·update13 Nov 2025 21:00

$5.99

+0.03
arrow_drop_up0.50%
Post-market·update14 Nov 2025 00:57
Day's Range
5.86-6.06
52-week Range
5.24-8.5

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-05
Next Earnings TimeAfter Market Close
Volume440.11K
Average Volume 30d360.9K

AI TPVG Summary

Powered by LiveAI
💰
10.2
Valuation (P/E Ratio)
This is the P/E ratio for TTM.
📈
-0.152
EPS Growth (YoY)
This is the YoY EPS growth rate calculated from the latest two available annual EPS values.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
78

TriplePoint Venture Growth BDC Corp. exhibits a mixed profile with strong dividend yields and positive profitability trends, but faces some headwinds in revenue growth and faces a strong dividend yield which may indicate a mature company.

Neutral

Thematic

60

The company operates within the venture capital and growth stage investment sector, which is inherently linked to technological innovation and economic growth cycles. Its focus on technology and life sciences aligns with current growth themes, but its specific strategy as a BDC might limit its direct thematic impact compared to pure-play tech companies.

Strong

Fundamental

75

The company demonstrates robust profitability with strong net margins and positive earnings per share, supported by consistent dividend payouts. However, recent revenue figures show a significant downturn, and debt levels have increased.

Neutral

Technical

65

The stock is trading below key moving averages, indicating a short-term bearish trend. While some oscillators suggest it is oversold, the overall technical picture points to caution.

FactorScore
Venture Capital & Growth Stage Investing70
Technology & Life Sciences Focus75
Economic Sensitivity50
BDC Structure Implications45
FactorScore
Valuation80
Profitability95
Growth15
Balance Sheet Health55
Cash Flow70
Dividend Yield90
FactorScore
Trend Analysis40
Momentum50
Volume Confirmation50
Support & Resistance70
Moving Averages (Short-term)40

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Earnings Performance chevron_right

Positive EPS Surprises

The company has exceeded earnings per share (EPS) estimates in 4 of the last 8 quarters, with an average surprise of 6.0%.

Valuation chevron_right

Low P/E Ratio

The Price-to-Earnings (P/E) ratio of 10.2 is significantly lower than the industry average, suggesting potential undervaluation.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation chevron_right

High Price-to-Sales Ratio

The trailing Price-to-Sales (P/S) ratio of 7.5 is high, suggesting the market values each dollar of revenue more than the industry average.

Earnings Performance chevron_right

Negative EPS Surprise in Recent Quarters

The company reported a negative EPS surprise of -11.44% in Q2 2025 and -9.2% in Q1 2025, indicating recent underperformance.

Show More 🔒

Calendar

June 2025

16

Ex-Dividend Date

June 2025

30

Next Dividend Date

August 2025

7

Next Earnings Date

EPS Est.
Revenue Est.

H: $0.32

A: $0.30

L: $0.28

H: 24.90M

A: 23.75M

L: 22.40M

Profile

Websitetpvg.com
Employees (FY)0.00
ISINUS89677Y1001
FIGI-

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Seasonals

2025
2024
2023
2022
2021

Price Target

7.04 USD

The 39 analysts offering 1 year price forecasts for TPVG have a max estimate of 9.00 and a min estimate of 5.50.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
39.6M (98.54%)
Closely held shares
586K (1.46%)
40.2M
Free Float shares
39.6M (98.54%)
Closely held shares
586K (1.46%)

Capital Structure

Market cap
298.53M
Debt
398.83M
Minority interest
0.00
Cash & equivalents
45.9M
Enterprise value
651.46M

Valuation - Summary

Market Cap
299M
Net income
28.1M(9.43%)
Revenue
38.4M(12.85%)
299M
Market Cap
299M
Net income
28.1M(9.43%)
Revenue
38.4M(12.85%)
Price to earning ratio (P/E)10.60x
Price to sales ratio (P/S)7.80x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
45.53M
COGS
45.53M
Gross Profit
0.00
OpEx
13.49M
Operating Income
0.00
Other & Taxes
-32.05M
Net Income
32.05M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒